Originally published by our sister publication Pain Medicine News
Naloxone, an opioid receptor antagonist that reverses the effects of an opioid overdose, is now available over the counter, following approval by the FDA.
The approval comes about a month after two FDA advisory committees met and unanimously recommended that OTC naloxone be approved.
“If approved as a nonprescription product, naloxone nasal spray may be sold more broadly to the United States, in a greater variety of retail